Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence
Author:
Affiliation:
1. Department of Urology, Oslo University Hospital, Oslo, Norway
2. Institute of Cancer Research, Oslo University Hospital, Oslo, Norway
3. Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2788446/sivanesan_2022_oi_211249_1642641673.16387.pdf
Reference44 articles.
1. Role of robot-assisted radical prostatectomy in locally advanced prostate cancer.;Saika;Int J Urol,2018
2. Considering the role of radical prostatectomy in 21st century prostate cancer care.;Costello;Nat Rev Urol,2020
3. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer.;Cornford;Eur Urol,2021
4. A comparison of side-effects and quality-of-life in patients operated on for prostate cancer with and without salvage radiation therapy.;Braide;Scand J Urol,2020
5. Adverse effects of androgen deprivation therapy and strategies to mitigate them.;Nguyen;Eur Urol,2015
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinoma;Virchows Archiv;2024-07-23
2. The multifaceted role of beta‐blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders;The FASEB Journal;2024-07-08
3. Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer;American Journal of Clinical Oncology;2024-07-08
4. The Crosstalk between Nerves and Cancer—A Poorly Understood Phenomenon and New Possibilities;Cancers;2024-05-15
5. Salbutamol, a short acting beta-2 agonist, reduces risk and improves prognosis of prostate cancer;2024-02-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3